Interstitial Lung Disease

Interstitial lung disease and pulmonary arterial hypertension associated with scleroderma often require consultations and co-management with physicians outside of rheumatology.

The Healio Editors compiled the most-read news in pulmonology posted in May.

United Therapeutics Corp. announced that the FDA has approved the Tyvaso dry powder inhaler for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease to improve exercise ability.

SAN FRANCISCO — A session at the American Thoracic Society International Conference highlighted a new clinical practice guideline addressing idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults.

DESTIN, Fla. — Although not currently curable, the symptoms of Sjögren’s syndrome, like dry eyes and dry mouth, can be effectively managed using a variety of therapies, said a speaker said at the Congress of Clinical Rheumatology East 2022 meeting.

Cough-specific quality of life was independently associated with respiratory hospitalization, mortality and lung transplantation among patients with interstitial lung disease, researchers reported in Chest.

Immune responses to COVID-19 vaccinations may trigger acute exacerbations in idiopathic pulmonary fibrosis among susceptible patients, according to data published in the American Journal of Respiratory and Critical Care Medicine.

The last 3 years of drug development in scleroderma have come to represent everything that ails the current pipeline for that disease.

Nintedanib reduces the rate of forced vital capacity decline more significantly in patients with systemic sclerosis-associated interstitial lung disease who reported no dyspnea or cough at baseline, data show.

In the past decade, the incidence of idiopathic pulmonary fibrosis nearly tripled and prevalence more than doubled among U.S. veterans, according to an analysis published in the Annals of the American Thoracic Society.